Lysosome–autophagy networks in lung development, maturation, and pediatric lung disease
- 1Department of Pediatrics, Shengjing Hospital of China Medical University , , ,
- 2Department of Pathology, The First Hospital and The College of Basic Medical Sciences of China Medical University , , ,
Abstract
Lysosomes are increasingly recognized as dynamic regulatory organelles that integrate degradation, nutrient sensing, lipid metabolism, membrane trafficking, and organelle quality control beyond their classical degradative functions. These activities are particularly important during lung development, when epithelial differentiation, alveolarization, lung maturation, surfactant homeostasis, and postnatal adaptation occur within a narrow developmental window. This review summarizes current evidence linking lysosome–autophagy networks to lung maturation, with emphasis on epithelial autophagy, alveolar type II (AT-II) cell function, lamellar-body biology, mitochondrial quality control, and alveolar macrophage regulation. We discuss how lysosomal lipid handling, autophagic flux, and mechanistic target of rapamycin (mTOR)–transcription factor EB (TFEB) signaling contribute to developmental homeostasis while distinguishing direct pulmonary evidence from mechanistic hypotheses derived from other systems. We further examine lysosomal and autophagic alterations in pediatric lung diseases, including bronchopulmonary dysplasia, cystic fibrosis, and viral respiratory infection, highlighting disease-specific upstream stressors and intracellular defects. Static autophagy markers cannot define functional flux, and conventional lysosomes must be distinguished from specialized lysosome-related organelles such as lamellar bodies. Finally, we discuss therapeutic opportunities and challenges, emphasizing cell-specific targeting, restoration of defined organelle defects, developmental safety, and rigorous functional validation. A developmentally informed understanding of lysosome–autophagy networks may provide new mechanistic frameworks for pediatric lung disease intervention.
Related
- Autophagy-lysosome flux failure in diabetic kidney disease: tubular vulnerability and cell-state remodeling
- Development and validation of a long-term co-maturation protocol for human stem cell-derived microglia and neuronal networks
- Autophagy-lysosome pathway dysfunction in MASLD progression: molecular mechanisms and therapeutic targets.
- Alcohol disrupts spatial coordination of autophagy–lysosome pathways to impair intestinal barrier integrity
- Exercise Is Associated with Skeletal Muscle Autophagy–Lysosome-Related Markers and Nrf2/ARF1 Signaling in HFD Mice
BibTeX
@article{song2026lysosomeautophagy,
title = {{Lysosome–autophagy networks in lung development, maturation, and pediatric lung disease}},
author = {Yajie Song and Dingning Zhang and Jiahui Bao and Guiyang Jiang and Dan Zhang},
journal = {Frontiers in pediatrics},
year = {2026},
month = oct,
doi = {10.3389/fped.2026.1967172},
url = {https://europepmc.org/article/PMC/PMC13724326},
note = {CC BY},
}
RIS
TY - JOUR
TI - Lysosome–autophagy networks in lung development, maturation, and pediatric lung disease
AU - Yajie Song
AU - Dingning Zhang
AU - Jiahui Bao
AU - Guiyang Jiang
AU - Dan Zhang
PY - 2026
DA - 2026/10/19
JO - Frontiers in pediatrics
DO - 10.3389/fped.2026.1967172
UR - https://europepmc.org/article/PMC/PMC13724326
AB - Lysosomes are increasingly recognized as dynamic regulatory organelles that integrate degradation, nutrient sensing, lipid metabolism, membrane trafficking, and organelle quality control beyond their classical degradative functions. These activities are particularly important during lung development, when epithelial differentiation, alveolarization, lung maturation, surfactant homeostasis, and postnatal adaptation occur within a narrow developmental window. This review summarizes current evidence linking lysosome–autophagy networks to lung maturation, with emphasis on epithelial autophagy, alveolar type II (AT-II) cell function, lamellar-body biology, mitochondrial quality control, and alveolar macrophage regulation. We discuss how lysosomal lipid handling, autophagic flux, and mechanistic target of rapamycin (mTOR)–transcription factor EB (TFEB) signaling contribute to developmental homeostasis while distinguishing direct pulmonary evidence from mechanistic hypotheses derived from other systems. We further examine lysosomal and autophagic alterations in pediatric lung diseases, including bronchopulmonary dysplasia, cystic fibrosis, and viral respiratory infection, highlighting disease-specific upstream stressors and intracellular defects. Static autophagy markers cannot define functional flux, and conventional lysosomes must be distinguished from specialized lysosome-related organelles such as lamellar bodies. Finally, we discuss therapeutic opportunities and challenges, emphasizing cell-specific targeting, restoration of defined organelle defects, developmental safety, and rigorous functional validation. A developmentally informed understanding of lysosome–autophagy networks may provide new mechanistic frameworks for pediatric lung disease intervention.
SN - 2296-2360
ER -